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ABSTACT
Background: Rheumatoid  arthritis  (RA)  is  a  chronic  progressive  autoimmune  disorder  characterized  by
symmetric  erosive  synovitis  and  sometimes  shows  multisystem  involvement.  The  long-term  outcome  of  the
disease is characterized by significant morbidity and increased mortality. Elevated free radical generations in
inflamed joints and impaired antioxidant system have been implicated in RA. Nitric oxide (NO) can also induce
tissue damage, especially after conversion into peroxynitrite radical (ONOO
). Aims: To estimate the serum
levels  of  MDA,  Nitric  Oxide  (NO)  and  Vitamin  E  in  patients  with  Rheumatoid  Arthritis. Materials  and
Methods: The study includes 50 RA patients who were fulfilling the American Rheumatism Association 1987
revised criteria for classification of RA and 50 age and sex matched healthy subjects without any major illness
were considered as controls. MDA, NO and Vitamin E were estimated in serum. Results: The estimated mean
levels (mean ± SD) of serum MDA, NO, Vitamin E, in control group were 3.55  0.30, 36.23  7.03, 14.61 
1.74, respectively and in patients with RA they were 5.39  0.79, 78.81  8.56, 10.56  1.72, respectively. The
statistical analysis by unpaired t-test shows that the levels of serum MDA and NO significantly  increased (p<
0.001) and the vitamin E levels were significantly decreased (p < 0.001) in RA patients when compared to healthy
controls. Conclusion: The serum values of MDA, NO and Vitamin E all together provided fairly useful index of
oxidative stress in RA patients. The results of current study support the concept of oxidative stress leading to
tissue damage.
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INTRODUCTION
Rheumatoid  arthritis is  a  common  inflammatory
arthritis.  It  is  one  of  the preventable  disability
conditions. The  clinical  features  are  symmetrical
arthritis, both small and large joints are affected and
associated  with  extra-articular  manifestations.
1 It
affects approximately 1 to 2% of general population
world  wide
2 and  in  India  its  incidence  is  0.75%.
3
Women are affected three times more often than men.
The onset is most frequent during the fourth and fifth
decade of life.
4
It  is  believed  that  RA  is  an  auto-immune disease,
triggered by  exposure  of a  genetically  susceptible
person to  an  arthritogenic factor.  It involves  the
activation  of  CD4  +  helper  cells  mainly.  Then the
local release of inflammatory mediators occurs which
ultimately  damages  the joint.
5 The cytokines  also
DOI: 10.5958/j.2319-5886.3.2.067323
Triveni et al., Int J med Res Health Sci. 2014;3(2):322-325
stimulates endothelial  cells,  macrophages  and
polymorphonuclear leukocytes to produce NO.
6
Although  characteristic  feature  is  persistent
inflammation, the elevated generation of free radicals
in inflamed joints and impaired antioxidant systems
has been implicated in RA.
7 With this background
this study was designed to estimate the serum MDA,
NO and vitamin E  in  RA  patients and apparently
healthy    controls  from  Davangere  district  of
Karnataka.
MATERIALS AND METHODS
Fifty Rheumatoid arthritis patients who are fulfilling
the American Rheumatism Association 1987 revised
criteria for classification of RA
20, age from 20 to 70
years  and both  sex  and age, controls (N=50) were
included  in  the  present study from  Bapuji  Hospital
and  Chigateri  General  Hospital,  Davangere  (Both
these  hospitals  are  attached  to  teaching  institute,
J.J.M  Medical  College,  Davangere)  and  also  from
general  population.  The  study  was  approved  by
Ethical  and  Research  Committee  of J.J.M.  Medical
College,  Davangere  to  use  human  subjects  in  the
research study.
Exclusion  criteria: Patient  with  Osteoarthritis,
Tubercular  arthritis,  Arthritis  other  than  RA  fitting
into any syndromes and any other chronic systemic
disorders  like  cardiovascular  disorders,  diabetes
mellitus,  liver  diseases and  kidney  diseases  are
excluded from the study.
Venous  blood  from  all  the  subjects  was  collected
aseptically  from  anticubital  vein;  serum  was
separated  by  centrifuging  at  3,000 RPM for  10
minutes  and  kept  at  4
0C  until  analysis  was  carried
out.
Estimation of Serum Malondialdehyde (MDA):
Thiobarbituric acid method
8
Auto-oxidation of unsaturated fatty acids lead to the
formation  of  semistable  peroxides  which  then
undergo  a  series  of  reactions  to  form  short  chain
aldehydes  like  malondialdehyde.  One  molecule  of
MDA reacts with 2 molecules of Thiobarbituric acid
(TBA) with the elimination of 2 molecules of water
to yield pink crystalline pigment with an absorption
maximum  at  530  nm. Results  are  expressed  as
mol/L
Estimation of Serum Nitric Oxide (NO): Kinetic
Cadmium-Reduction method
9
Nitrate, the stable product of nitric oxide is reduced to
nitrite  by  Cadmium  reduction  method  after
deprotinization  with  Somogyi  reagent.  The  nitrite
produced  is  determined  by  diazotization  of
sulphanilamide and coupling to naphthylene ethylene
diamine. The color complex precipitated is measured
at 540nm wavelength using colorimeter. Results are
expressed as mol/L
Estimation  of Serum Vitamin E  (Tocopherols):
Baker and Frank method
10
Serum tocopherol  is measured  by  their  reduction
property.  They  reduce  ferric  ions  to  ferrous  ions
which are then reacts with , ’-dipyridyl to form a
red colored complex. First tocopherols and carotenes
are extracted by xylene and the reading is taken at
460 nm. A correction for the carotenes is made by
adding ferric chloride and then again reading is taken
at 520 nm. Results are expressed as mg/L
Statistic analysis: Results are expressed as mean 
SD. Unpaired‘t’ test was  used for  intergroup
comparison  and paired‘t’ test  for intra group
comparison. p < 0.05 was considered as statistically
significant.
RESULTS
Table1: Age and sex-wise distribution of controls
and RA patients
Controls
Mean  SD
Cases
Mean  SD
Age (yrs) 41.9  13.6 46.2  13.3
Gender Male 18 14
Female 32 36
Table 2: Serum levels of MDA, NO, Vitamin E in
patients with RA and healthy controls.
MDA
(mol/L)
NO (mol/L)
Vit.E
(mg/L)
Controls 3.55  0.30 36.23  7.03 14.61  1.74
Cases 5.39  0.79 78.81  8.56 10.56  1.72
Mean
difference
1.84 42.58 4.05
t-value* 15.44 27.19 11.68
p-level < 0.001, HS < 0.001, HS < 0.001, HS
*Unpaired  t-test                p<0.001=HS  (Highly
significant)   p>0.05=NS (Not significant)324
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DISCUSSION
In  the  present  study,  the  serum  level  of  MDA  is
highly statistically significantly increased (p < 0.001)
in patients with RA when compared to controls. In
RA  patients activated  macrophages  and  neutrophils
release oxidants in high  concentrations that lead  to
oxidative  stress.  This  will  cause  damage to  lipids,
proteins,  carbohydrates  and DNA.  The  unsaturated
fatty  acids  of cell  membranes undergo  lipid
peroxidation  and MDA  is  released  which  acts  as  a
oxidative  stmarker.
11 MDA reacts  with  lysine
residues  in  protein  to  produce  immunogenic
molecules, which can exacerbate inflammation.
12
Increased serum MDA concentration in RA suggests
the  role  of  free  radicals  in  pathogenesis  of
inflammatory arthropathy and supports the need for
studies assessing the therapeutic role of free radical
scavengers in RA.
2
NO is a pleiotropic mediator of inflammation which
was  discovered  as  factor  released  from  endothelial
cells that caused vasodilatation by relaxing vascular
smooth  muscle  and  was  therefore  called
endothelium–derived relaxing factor.
14 NO is a  short
lived radical and lipid and water soluble gas which as
a potent inflammatory mediator. Because of it reacts
with oxygen,  superoxide  and  iron-containing
compounds strongly.
15 NO is generated by the nitric
oxide  synthasase  (NOS)  enzyme  from  molecular
oxygen  and  the  terminal guanidine  nitrogen  of  the
amino  acid l-arginine,  yielding l-citrulline  as  a  co-
product. In our study, the serum NO level is highly
statistically significantly increased (p<0.001) in RA
patients as compared to healthy controls.There  may
be two possible causes for the increased serum levels
of  NO  in  RA.  One  is  enhanced synovial
inflammation, which results in increased levels of NO
in  synovial  fluid  which  ultimately  enters  systemic
circulation.  Another  possible  cause  may  be
production of NO by systemic vasculature and other
cells.
6
Nitric  oxide  can  induce tissue damage,  especially
after conversion into peroxynitrite radical (ONOO
.).
25
Peroxynitrite can be directly cytotoxic and it can also
decompose  to  give  range  of  products,  including
hydroxyl radicals (
 OH ) and nitronium ion (NO2
+).
NO  produced  within  the  inflamed  joint  may
contribute to the peri-articular bone loss in RA.
16
For cell membrane lipids and lipoprotein vitamin E
serves  as  a chain  breaking  free  radical trapping
antioxidant. It reacts with the lipid peroxide radical
before the establishment of chains lipid peroxidation
reactions occurs. In this process vitamin E produces
tocopheroxyl  free  radical  which is  unreactive  and
results in forms nonradical compound synthesis.
17 In
our study  the  levels  of  serum  vitamin  E  is  highly
statistically  significantly  reduced  (p<0.001)  in
patients  with  RA  when  compared  to  controls.  The
decrease in vitamin E level may be the for preventing
oxidative  stress ,  turnover  of vitamin E  can  occur
more in RA.
18 An epidemiological study suggested
that low alpha-tocopherol status is a risk factor for
RA independently of rheumatoid factor status.
19
CONCLUSION
The enhanced oxidation plays a significant role in the
tissue damage and inflammation perpetuating process
in  rheumatoid  synovium.  The  oxygen  free radicals
lead to lipid peroxidation and bone loss. The results
of  current  study  support  the  concept  of  oxidative
stress leading to tissue damage. As a consequence of
the present understanding of the etiopathogenesis of
RA, exogenous antioxidants i.e., Vitamins and other
nutrients, appear to be potential agents for therapeutic
management.
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